Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShort-Term Debt repayments
Ratios

Cue Biopharma (CUE) Shares Repurchased (2020 - 2022)

Cue Biopharma (CUE) has disclosed Shares Repurchased for 3 consecutive years, with $9000.0 as the latest value for Q3 2022.

  • Quarterly Shares Repurchased fell 98.13% to $9000.0 in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $9000.0 through Jun 2023, down 98.95% year-over-year, with the annual reading at $200000.0 for FY2022, 73.34% down from the prior year.
  • Shares Repurchased hit $9000.0 in Q3 2022 for Cue Biopharma, down from $191000.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $482000.0 in Q3 2021 to a low of $9000.0 in Q3 2022.
  • Historically, Shares Repurchased has averaged $163597.0 across 3 years, with a median of $160051.0 in 2020.
  • Biggest five-year swings in Shares Repurchased: surged 1277.14% in 2021 and later plummeted 98.13% in 2022.
  • Year by year, Shares Repurchased stood at $160051.0 in 2020, then grew by 14.42% to $183128.0 in 2021, then crashed by 95.09% to $9000.0 in 2022.
  • Business Quant data shows Shares Repurchased for CUE at $9000.0 in Q3 2022, $191000.0 in Q1 2022, and $183128.0 in Q4 2021.